Hansa Biopharma AB
STO:HNSA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
21.12
42.74
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
HNSA
stock under the Base Case scenario is
hidden
SEK.
Compared to the current market price of 33.92 SEK,
Hansa Biopharma AB
is
hidden
.
Valuation History
Hansa Biopharma AB
HNSA looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if HNSA is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Hansa Biopharma AB.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Hansa Biopharma AB
Balance Sheet Decomposition
Hansa Biopharma AB
Hansa Biopharma AB
Free Cash Flow Analysis
Hansa Biopharma AB
| SEK | |
| Free Cash Flow | SEK |
Earnings Waterfall
Hansa Biopharma AB
HNSA Profitability Score
Profitability Due Diligence
Score
HNSA Solvency Score
Solvency Due Diligence
Score
Wall St
Price Targets
HNSA Price Targets Summary
Hansa Biopharma AB
According to Wall Street analysts, the average 1-year price target for
HNSA
is 78.54 SEK
with a low forecast of 33.33 SEK and a high forecast of 116.55 SEK.
Dividends
Current shareholder yield for
HNSA is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
HNSA
stock under the Base Case scenario is
hidden
SEK.
Compared to the current market price of 33.92 SEK,
Hansa Biopharma AB
is
hidden
.